Literature DB >> 2359296

Glucose uptake and amino acid metabolism in perfused hearts from tumor-bearing rats.

C Drott1, K Lundholm.   

Abstract

The purpose of this study was to evaluate whether heart glucose metabolism can account for elevated heart oxygen consumption in a tumor-bearing host. This is the first report of altered metabolism in perfused hearts from tumor-bearing animals. Glucose, glycerol, lactate, and amino acid metabolism was examined under steady-state conditions in isolated perfused hearts from sarcoma-bearing rats and compared to the metabolism in hearts from starved (96 hr) and fed control rats. Heart dry weight was reduced by 10% in tumor-bearing rats and by 30% in starved rats when compared to freely fed control animals. Cardiac glucose uptake was decreased in tumor-bearing rats (206 +/- 33 mumoles/hr/g dry wt) compared to both starved (298 +/- 18) and fed control rats (293 +/- 25). Hearts from both fed and starved controls released lactate and glycerol at significant rates during perfusion which was not evident in hearts from tumor-bearing rats. The release of individual amino acids from working hearts during perfusion was different among the animal groups with a severe depression of both glutamine and alanine release in tumor-bearing rats. In starved rats alanine release was normal although glutamine release was depressed by more than 50%. The net release of all amino acids was lowest in hearts from tumor-bearing rats, intermediate in the starved animals, and highest in the control animals, while the nonmetabolized amino acids (phenylalanine, tyrosine, methionine) were released at increased rates only from tumor-host hearts, indicating an increased net breakdown of some cardiac proteins in tumor-bearing animals.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2359296     DOI: 10.1016/0022-4804(90)90112-f

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

Review 1.  Cancer cachexia: understanding the molecular basis.

Authors:  Josep M Argilés; Sílvia Busquets; Britta Stemmler; Francisco J López-Soriano
Journal:  Nat Rev Cancer       Date:  2014-10-09       Impact factor: 60.716

Review 2.  Understanding the molecular basis of anorexia and tissue wasting in cancer cachexia.

Authors:  Eunbyul Yeom; Kweon Yu
Journal:  Exp Mol Med       Date:  2022-04-06       Impact factor: 12.153

Review 3.  Cardiac Remodeling in Cancer-Induced Cachexia: Functional, Structural, and Metabolic Contributors.

Authors:  Michael P Wiggs; Anna G Beaudry; Michelle L Law
Journal:  Cells       Date:  2022-06-15       Impact factor: 7.666

4.  Theophylline is able to partially revert cachexia in tumour-bearing rats.

Authors:  Mireia Olivan; Jochen Springer; Sílvia Busquets; Anika Tschirner; Maite Figueras; Miriam Toledo; Cibely Fontes-Oliveira; Maria Inés Genovese; Paula Ventura da Silva; Angelica Sette; Francisco J López-Soriano; Stefan Anker; Josep M Argilés
Journal:  Nutr Metab (Lond)       Date:  2012-08-21       Impact factor: 4.169

Review 5.  Nonmuscle Tissues Contribution to Cancer Cachexia.

Authors:  Josep M Argilés; Britta Stemmler; Francisco J López-Soriano; Silvia Busquets
Journal:  Mediators Inflamm       Date:  2015-10-07       Impact factor: 4.711

6.  Formoterol in the treatment of experimental cancer cachexia: effects on heart function.

Authors:  Míriam Toledo; Jochen Springer; Sílvia Busquets; Anika Tschirner; Francisco J López-Soriano; Stefan D Anker; Josep M Argilés
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-08-29       Impact factor: 12.910

Review 7.  Understanding cachexia as a cancer metabolism syndrome.

Authors:  P E Porporato
Journal:  Oncogenesis       Date:  2016-02-22       Impact factor: 7.485

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.